Patent intelligence · US
US 11331365
Multispecific protein drug and library thereof, preparing method therefor and application thereof
Multispecific protein drug and library thereof, preparing method therefor and application thereof
Patent details — US 11331365
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 17, 2022
- Expiration
- May 12, 2042
- Applicant
- Assembly Medicine, LLC
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61K38/02, A61K47/549
Quick answer
US 11331365 (Multispecific protein drug and library thereof, preparing method therefor and application thereof) is held by Assembly Medicine, LLC. Status: granted. Granted May 17, 2022. Expires May 12, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Assembly Medicine, LLC
- Grant date
- Expiration
- Claims
- 10
- CPC classes
- A61K, A61K38/00, A61K38/02, A61K47/549, A61K47/61
More from Assembly Medicine, LLC
Related pharmaceutical patents in our USPTO index.
-
US 12030869
5-membered heteroaryl carboxamide compounds for treatment of HBV
granted -
US 11814376
Hepatitis b core protein modulators
granted -
US 11560370
5-membered heteroaryl carboxamide compounds for treatment of HBV
granted -
US 11078170
Cyclic sulfamide compounds and methods of using same
granted -
US 11040965
Process for making Hepatitis B core protein modulators
granted -
US 10987360
Hepatitis B core protein modulators
granted -
US 10968211
Hepatitis B core protein modulators
granted
Frequently asked questions
What is US patent 11331365?
US 11331365 (Multispecific protein drug and library thereof, preparing method therefor and application thereof) is held by Assembly Medicine, LLC. Status: granted. Granted May 17, 2022. Expires May 12, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11331365?
Assembly Medicine, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 14 pharmaceutical patents for this assignee.
When does US 11331365 expire?
Our index shows an expiration date of May 12, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.